Video Latest - ecancer

Development of novel inhibitors of KRASG12C

Dr Kevan Shokat - University of California San Francisco, San Francisco, USA

4 Nov 2020

Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy

Dr Julius Strauss - National Institutes of Health, Bethseda, USA

4 Nov 2020

Critical issues in drug and biomarker development

Prof Tracy Lively - National Cancer Institute, USA

2 Nov 2020

OncoAlert and ecancer weekly roundup for October 26 - 31, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

2 Nov 2020

Treating elderly cancer patients during the COVID-19 pandemic

Dr Anna Mislang - Flinders Private Hospital, Bedford Park, Australia

30 Oct 2020

Pragmatic geriatric assessment for cancer patients in Brazil

Dr Antonio Fabiano Ferreira Filho - Oncosinos, Novo Hamburgo, Brazil

30 Oct 2020

OncoAlert and ecancer weekly roundup for October 19-26, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

28 Oct 2020

Highlights from EBCC-12

Prof Nadia Harbeck - EBCC Conference Chair

23 Oct 2020

OncoAlert and ecancer weekly roundup for October 12 - 18, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

23 Oct 2020

Overview of the MINDACT trial results presented at EBCC-12

Prof Etienne Brain - EORTC Breast cancer group chair

16 Oct 2020

EBCC-12 during COVID-19

Prof Etienne Brain - EORTC Breast cancer group chair

16 Oct 2020

Why don’t all European breast cancer patients get the most appropriate care?

Prof Philip Poortmans - Antwerp University, Antwerp, Belgium

15 Oct 2020

Video